1. Home
  2. JAKK vs TNXP Comparison

JAKK vs TNXP Comparison

Compare JAKK & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAKK
  • TNXP
  • Stock Information
  • Founded
  • JAKK 1995
  • TNXP 2007
  • Country
  • JAKK United States
  • TNXP United States
  • Employees
  • JAKK N/A
  • TNXP N/A
  • Industry
  • JAKK Recreational Games/Products/Toys
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • JAKK Consumer Discretionary
  • TNXP Health Care
  • Exchange
  • JAKK Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • JAKK 230.6M
  • TNXP 272.0M
  • IPO Year
  • JAKK 1996
  • TNXP N/A
  • Fundamental
  • Price
  • JAKK $20.80
  • TNXP $37.86
  • Analyst Decision
  • JAKK Strong Buy
  • TNXP Strong Buy
  • Analyst Count
  • JAKK 4
  • TNXP 2
  • Target Price
  • JAKK $41.75
  • TNXP $585.00
  • AVG Volume (30 Days)
  • JAKK 124.6K
  • TNXP 691.0K
  • Earning Date
  • JAKK 07-30-2025
  • TNXP 08-15-2025
  • Dividend Yield
  • JAKK 4.83%
  • TNXP N/A
  • EPS Growth
  • JAKK 47.04
  • TNXP N/A
  • EPS
  • JAKK 4.03
  • TNXP N/A
  • Revenue
  • JAKK $714,219,000.00
  • TNXP $10,041,000.00
  • Revenue This Year
  • JAKK N/A
  • TNXP $11.66
  • Revenue Next Year
  • JAKK $3.90
  • TNXP $793.18
  • P/E Ratio
  • JAKK $5.13
  • TNXP N/A
  • Revenue Growth
  • JAKK 2.89
  • TNXP N/A
  • 52 Week Low
  • JAKK $17.20
  • TNXP $6.76
  • 52 Week High
  • JAKK $35.79
  • TNXP $130.00
  • Technical
  • Relative Strength Index (RSI)
  • JAKK 50.34
  • TNXP 54.68
  • Support Level
  • JAKK $20.10
  • TNXP $33.20
  • Resistance Level
  • JAKK $21.15
  • TNXP $38.13
  • Average True Range (ATR)
  • JAKK 0.71
  • TNXP 2.19
  • MACD
  • JAKK -0.03
  • TNXP -0.33
  • Stochastic Oscillator
  • JAKK 63.13
  • TNXP 71.27

About JAKK JAKKS Pacific Inc.

Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells and distributes toys and related kid-targeted consumer products, inclusive of kids indoor and outdoor furniture, costumes and various product lines in the sporting goods and home furnishings space. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: (i) Toys/Consumer Products and (ii) Costumes.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: